Vivotif
Payments companies reported to CMS as associated with Vivotif. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vivotif, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vivotif
These are the largest totals companies reported as associated with Vivotif. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Mccarty | Madera, CA | Pediatric Infectious Diseases | $13,650.00 |
| Alicia Peacock | Lakewood, CO | Family | $308.06 |
| Anne Murphy | Colorado Springs, CO | Family | $146.28 |
| Margaret Galvan | Haverford, PA | Family | $82.97 |
| Sandra Savage | Nashville, TN | Family | $82.97 |
| Shahbaz Qalbani | Saint Louis, MO | Family Medicine | $82.97 |
| David Switzer | Luray, VA | Family Medicine | $82.97 |
| Anne Kimberly | Portland, OR | Registered Nurse | $82.97 |
| Laura Burkhart | Nashville, TN | Family Medicine | $82.97 |
| Alison Schut | Holland, MI | Adult Health (Nurse Practitioner) | $82.97 |
Prescribed Vivotif?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.